Cell BioEngines

Off-the-shelf curative cell therapies for all patients

New York, United States · Founded 2022

Headquarters
New York, New York
Employees
1–10
Founded
2022
Business Model
B2B
Last Round
SeedJul 2024
Rounds
2

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Cell BioEngines is a clinical-stage biotechnology company pioneering off-the-shelf, allogeneic cell therapies for oncology and regenerative medicine. Founded in December 2022, the company's proprietary STEM-Space™ platform enables transgene-free chemical reprogramming of stem cells without genetic engineering, combined with HLA-guided design and a population-informed biobank to achieve broad patient coverage. Unlike autologous therapies that require patient-specific manufacturing, Cell BioEngines' approach enables scalable, low-cost production of standardized cell-based therapeutics that can be stockpiled and distributed like conventional drugs.

Summary

Cell BioEngines is a Biotech company based in New York, United States, founded in 2022. Its most recent funding was a Seed round in Jul 2024. Investors include SOSV and IndieBio.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJul 2024

Sign up to see all 2 events

Funding: Pre-Seed through Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture RoundTotal funding$884.0MJul 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cell BioEngines on Indexed.vc
<a href="https://indexed.vc/companies/cell-bioengines"><img src="https://indexed.vc/api/badge/company/cell-bioengines" alt="Cell BioEngines on Indexed.vc" width="260" height="76" /></a>